Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

17.58
Delayed Data
As of Aug 24
 -0.58 / -3.19%
Today’s Change
9.16
Today|||52-Week Range
18.70
+4.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues81.2M148.9M200.7M230.8M
 
 
 
 
 
Cost of Goods Sold15.9M24.2M15.6M21.2M
 
 
 
 
 
Depreciation And Amortization14.5M14.3M12.9M12.9M
 
 
 
 
 
 
Operating ExpensesGross Income50.8M110.4M172.2M196.7M
 
 
 
 
 
General Expenses190.3M219.2M188.7M223.1M
 
 
 
 
 
Research And Development148.7M178.7M147.7M182.8M
 
 
 
 
 
Total Operating Expenses220.7M257.8M217.2M257.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-139.5M-108.8M-16.5M-26.4M
 
 
 
 
 
Extraordinary Charge-1.7M-11.3M---17.1M
 
 
 
 
Interest Expense On Debt33.5M40.8M38.8M38.9M
 
 
 
 
 
Other Expenses983.0K392.0K814.0K1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-171.4M-159.8M-54.4M-80.7M
 
 
 
 
 
Income Taxes-406.0K-2.2M-512.0K-506.0K
 
 
 
 
 
Net Income-171.9M-162.0M-53.9M-81.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS114.8M115.7M126.9M132.5M
 
 
 
 
 
Shares To Calculate EPS Diluted114.8M115.7M126.9M132.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.50-$1.40-$0.42-$0.61
 
 
 
 
 
EPS Diluted-$1.50-$1.40-$0.42-$0.61